Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

ACRO Biomedical Co., Ltd. (6748) Financial Statements

ACRO Biomedical Co., Ltd. Financial Overview

ACRO Biomedical Co., Ltd.'s market cap is currently NT$12.15B. The company's EPS TTM is NT$-1.78; its P/E ratio is -96.07; ACRO Biomedical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 38.26MNT$ 44.23MNT$ 51.06MNT$ 27.63MNT$ 21.83M
Gross ProfitNT$ 12.17MNT$ 26.19MNT$ 39.12MNT$ 13.43MNT$ 14.54M
Operating IncomeNT$ -92.22MNT$ -66.50MNT$ -48.67MNT$ -62.77MNT$ -53.55M
EBITDANT$ -75.68MNT$ -48.31MNT$ -30.18MNT$ -51.57MNT$ -41.18M
Net IncomeNT$ -82.66MNT$ -62.09MNT$ -41.42MNT$ -60.88MNT$ -50.77M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 977.87MNT$ 498.95MNT$ 579.23MNT$ 316.85MNT$ 62.97M
Total AssetsNT$ 1.13BNT$ 655.33MNT$ 716.74MNT$ 398.53MNT$ 151.28M
Total DebtNT$ 10.59MNT$ 15.85MNT$ 21.66MNT$ 11.82MNT$ 13.37M
Net DebtNT$ -760.08MNT$ -175.90MNT$ -522.50MNT$ -270.02MNT$ -18.90M
Total LiabilitiesNT$ 28.11MNT$ 29.05MNT$ 30.66MNT$ 19.92MNT$ 21.27M
Stockholders' EquityNT$ 1.10BNT$ 626.28MNT$ 686.08MNT$ 378.61MNT$ 130.02M
Cash Flow
Free Cash FlowNT$ -62.96MNT$ -74.01MNT$ -70.73MNT$ -49.59MNT$ -51.13M
Operating Cash FlowNT$ -49.01MNT$ -43.38MNT$ -48.27MNT$ -45.15MNT$ -47.83M
Investing Cash FlowNT$ 84.41MNT$ -304.67MNT$ -33.59MNT$ -10.54MNT$ 36.85M
Financing Cash FlowNT$ 544.76MNT$ -5.25MNT$ 345.28MNT$ 304.40MNT$ -3.42M

Currency in TWD

ACRO Biomedical Co., Ltd. Earnings and Revenue History

-120M-60M060M-300 %-200 %-100 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

ACRO Biomedical Co., Ltd. Liabilities to Assets

0400M800M1.2B0 %5 %10 %15 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

ACRO Biomedical Co., Ltd. Cash Flow

-400M-200M0200M400M600M202020212022202320242025OperatingInvestingFinancing
Cash Flow >

ACRO Biomedical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >